William Duke, Jr
2019
In 2019, William Duke, Jr earned a total compensation of $1.7M as Chief Financial Officer principal financial officer at Kaleido Biosciences.
Compensation breakdown
Option Awards | $1,675,995 |
---|---|
Salary | $44,692 |
Other | $277 |
Total | $1,720,964 |
Duke received $1.7M in option awards, accounting for 97% of the total pay in 2019.
Duke also received $44.7K in salary and $277 in other compensation.
Rankings
In 2019, William Duke, Jr's compensation ranked 6,653rd out of 13,971 executives tracked by ExecPay. In other words, Duke earned more than 52.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,653 out of 13,971 | 52nd |
Division Manufacturing | 2,530 out of 5,701 | 56th |
Major group Chemicals And Allied Products | 918 out of 2,200 | 58th |
Industry group Drugs | 776 out of 1,886 | 59th |
Industry Biological Products, Except Diagnostic Substances | 186 out of 389 | 52nd |
Source: SEC filing on May 5, 2021.
Duke's colleagues
We found four more compensation records of executives who worked with William Duke, Jr at Kaleido Biosciences in 2019.